Implication of the glutamate-cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis.

Fournier, M; Monin, A; Ferrari, C; Baumann, P S; Conus, P; Do, K

Fournier, M; Monin, A; Ferrari, C; Baumann, P S; Conus, P; Do, K.

Afiliación

Fournier M; Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Switzerland, Switzerland.
Monin A; Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Switzerland, Switzerland.
Ferrari C; Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Switzerland, Switzerland.
Baumann PS; Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Switzerland, Switzerland.
Conus P; Department of Psychiatry, Service of general psychiatry, Lausanne University Hospital, Switzerland, Switzerland.
Do K; Department of Psychiatry, Service of general psychiatry, Lausanne University Hospital, Switzerland, Switzerland.

NPJ Schizophr ; 3(1): 31, 2017 Sep 18.

Article en En | MEDLINE | ID: mdl-28924227

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Schizophr Año: 2017 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google